Differential impact of adipokines derived from primary adipocytes of wild-type versus streptozotocin-induced diabetic rats on glucose and fatty acid metabolism in cardiomyocytes

Journal of Endocrinology

Volumn 199, Issue 3, 2008, Pages 389-397

  Palanivel, Rengasamy ^a   Vu, Vivian ^a   Park, Min ^a   Fang, Xiangping ^a   Sweeney, Gary ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPOCYTOKINE; INTERLEUKIN 6; LACTIC ACID; LEPTIN; PROTEIN KINASE B;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL METABOLISM; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART MUSCLE CELL; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOCIN DIABETES; WILD TYPE;

ADIPOCYTES; ADIPOKINES; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS; GLUCOSE; GLYCOGEN; IMMUNOBLOTTING; LACTIC ACID; MALE; MYOCYTES, CARDIAC; RATS; RATS, WISTAR;

EID: 57449088583     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0336     Document Type: Article

References (31)

1. Abel ED, Litwin SE & Sweeney G 2008 Cardiac remodeling in obesity. Physiological Reviews 88 389-419.
2. An D & Rodrigues B 2006 Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology 291 H1489-H1506.
3. Badman MK & Flier JS 2007 The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 132 2103-2115.
4. Borradaile NM & Schaffer JE 2005 Lipotoxicity in the heart. Current Hypertension Reports 7 412-417.
5. Bradham WS, Bozkurt B, Gunasinghe H, Mann D & Spinale FG 2002 Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovascular Research 53 822-830.
6. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE & Abel ED 2005 Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146 5341-5349.
7. Carey AL & Febbraio MA 2004 Interleukin-6 and insulin sensitivity: friend or foe? Diabetologia 47 1135-1142.
8. Ceddia RB, Koistinen HA, Zierath JR & Sweeney G 2002 Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB Journal 16 1163-1176.
9. Chatham JC, Gao ZP, Bonen A & Forder JR 1999a Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes. Cardiovascular Research 43 96-106.
10. Chatham JC, Gao ZP & Forder JR 1999b Impact of 1 wk of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation. American Journal of Physiology 277 E342-E351.
11. Golfman LS, Wilson CR, Sharma S, Burgmaier M, Young ME, Guthrie PH, Van Arsdall M, Adrogue JV, Brown KK & Taegtmeyer H 2005 Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. American Journal of Physiology. Endocrinology and Metabolism 289 E328-E336.
12. Graveleau C, Zaha VG, Mohajer A, Banerjee RR, Dudley-Rucker N, Steppan CM, Rajala MW, Scherer PE, Ahima RS, Lazar MA et al. 2005 Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action. Journal of Biological Chemistry 280 31679-31685.
13. Guo Z, Xia Z, Yuen VG & McNeill JH 2007 Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats. Metabolism 56 1363-1371.
14. Hopkins TA, Ouchi N, Shibata R & Walsh K 2007 Adiponectin actions in the cardiovascular system. Cardiovascular Research 74 11-18.
15. Karmazyn M, Purdham DM, Rajapurohitam V & Zeidan A 2007 Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends in Cardiovascular Medicine 17 206-211.
16. Li L, Wu L, Wang C, Liu L & Zhao Y 2007 Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes. Regulatory Peptides 139 72-79.
17. Liu Y, Retnakaran R, Hanley A, Tungtrongchitr R, Shaw C & Sweeney G 2007 Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. Journal of Clinical Endocrinology and Metabolism 92 4313-4318.
18. Lopaschuk GD, Folmes CD & Stanley WC 2007 Cardiac energy metabolism in obesity. Circulation Research 101 335-347.
19. McGavock JM, Victor RG, Unger RH & Szczepaniak LS 2006 Adiposity of the heart, revisited. Annals of Internal Medicine 144 517-524.
20. Palanivel R, Eguchi M, Shuralyova I, Coe I & Sweeney G 2006 Distinct effects of short- and long-term leptin treatment on glucose and fatty acid uptake and metabolism in HL-1 cardiomyocytes. Metabolism 55 1067-1075.
21. Palanivel R, Fang X, Park M, Eguchi M, Pallan S, De Girolamo S, Liu Y, Wang Y, Xu A & Sweeney G 2007 Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes. Cardiovascular Research 75 148-157.
22. Park SY, Cho YR, Kim HJ, Higashimori T, Danton C, Lee MK, Dey A, Rothermel B, Kim YB, Kalinowski A et al. 2005 Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54 3530-3540.
23. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T et al. 2004 Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109 2191-2196.
24. Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J, Dieguez C, Gualillo O, Gonzalez-Juanatey JR & Lago F 2005 Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Letters 579 5163-5169.
25. Purdham DM, Zou MX, Rajapurohitam V & Karmazyn M 2004 Rat heart is a site of leptin production and action. American Journal of Physiology. Heart and Circulatory Physiology 287 H2877-H2884.
26. Ramanadham S, Doroudian A & McNeill JH 1990 Myocardial and metabolic abnormalities in streptozotocin-diabetic Wistar and Wistar-Kyoto rats. Canadian Journal of Cardiology 6 75-82.
27. Schaffer JE 2003 Lipotoxicity: when tissues overeat. Current Opinion in Lipidology 14 281-287.
28. Shiomi T, Tsutsui H, Ikeuchi M, Matsusaka H, Hayashidani S, Suematsu N, Wen J, Kubota T & Takeshita A 2003 Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. Journal of the American College of Cardiology 42 165-172.
29. Stanley WC, Recchia FA & Lopaschuk GD 2005 Myocardial substrate metabolism in the normal and failing heart. Physiological Reviews 85 1093-1129.
30. Vu V, Kim W, Fang X, Liu YT, Xu A & Sweeney G 2007 Coculture with primary visceral rat adipocytes from control but not streptozotocin-induced diabetic animals increases glucose uptake in rat skeletal muscle cells: role of adiponectin. Endocrinology 148 4411-4419.
31. Wang P, Lloyd SG, Zeng H, Bonen A & Chatham JC 2005 Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. American Journal of Physiology. Heart and Circulatory Physiology 288 H2102-H2110.